Tehran – Iran, which launched its first national production line for its electroporation system, has become the first country in Asia to acquire advanced cancer treatment techniques.
The inauguration ceremony for the Iranian device was held at the University of Tehran on Monday, the IRNA reported.
Homemade electrochemotherapy ablation systems (new methods for targeted treatment of cancerous tumors) are important outcomes that rely primarily on domestic technical knowledge and global standards.
Electroporation systems use electrical pulses to increase the permeability of cancer cells, greatly improving the effectiveness of anticancer agents.
Electroporation is extremely efficient in the treatment of skin cancers such as skin cell carcinoma (SCC), skin cancer, skin cancer, skin cancer, skin cancer, skin cancer, skin cancer, skin cancer, and skin cancer. It’s the upper layer of the skin, melanoma, and breast cancer.
Over 1,000 patients have been treated using this therapy so far. In more than 200 cases, successful treatment prevented the need for amputation.
According to an IRNA report in February, Iranian knowledge-based companies were able to develop a new method for the synthesis of Technetium (99MTC) Tilmanocept, a radiopharmaceutical diagnostic imaging agent used to determine lymph nodes that may be excreted from tumors.
Since 2013, the US is the only manufacturer of the radiopharmaceutical, the IRNA reported.
The lymphatic system is known as one of the major conduits of cancer metastasis. In patients with breast, lung and genital cancer, accurate detection of lymph node involvement is important for surgeons.
Thanks to this incredible achievement, approximately 90% of the various cancer patients in the country have access to more affordable and more accurate methods for cancer diagnosis and treatment.
After successfully passing through the preclinical phase, the drug entered the clinical phase.
mt/mg